61 Results for "

INS-1

" in MedChemExpress (MCE) Product Catalog:
Products (61)

61 Results for "INS-1" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-142114
CAS No.: 2322245-42-9
Purity:  99.16%
Target:  

Arrestin

Research Areas:  

Metabolic Disease

SRI-37330 is an orally bioavailable thioredoxin-interacting protein (TXNIP) inhibitor. SRI-37330 inhibits glucagon secretion and function, reduces hepatic glucose production and reverses hepatic steatosis. SRI-37330 can be used for type 2 diabetes research [1].
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N0668
CAS No.: 64849-39-4
Rubusoside is a diterpene glycoside that is also a sweetener and solubilizer with anti-angiogenic, anti-cancer, anti-obesity, anti-allergic and anti-asthmatic effects. Rubusoside attenuates airway hyperresponsiveness and reduces inflammatory cells in bronchoalveolar lavage fluid (BALF), reducing OVA (HY-W250978)-induced airway inflammation. Rubusoside also prevents palmitic acid-induced lipotoxicity in pancreatic INS-1 cells, reduces the transport of human glucose transporters GLUT-1 and fructose GLUT-5, and inhibits NF-κB and α-amylase (α-amylase) [1] .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-153347
CAS No.: 339103-05-8
Purity:  99.75%
Target:  

FOXO

Research Areas:  

Metabolic Disease

JY-2 is a moderately selective and orally active Forkhead transcription factor forkhead box O1 (FoxO1) inhibitor that inhibits FoxO1 transcriptional activity with an IC50 of 22 μM. JY-2 shows moderate inhibition against FoxO3a and FoxO4. JY-2 shows anti-diabetic activity [1].
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-126750
CAS No.: 1003019-41-7
Purity:  99.86%
Target:  

Phosphatase

Research Areas:  

Inflammation/Immunology

GNF362 is a selective, potent, and orally bioavailable inhibitor of inositol trisphosphate 3’ kinase B (Itpkb) with an IC50 of 9 nM. GNF362 also inhibits Itpka and Itpkc with IC50 values of 20 nM and 19 nM, respectively. Inositol trisphosphate 3’ kinase B (Itpkb) is a Ca 2+-dependent kinase, which phosphorylates the 3’ position of Ins (1,4,5) P3 to generate inositol 1,3,4,5-tetrakisphosphate [Ins (1,3,4,5) P4] [1].
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P10769
CAS No.: 2209854-03-3
Target:  

AMPK Apoptosis

Research Areas:  

Metabolic Disease

MOTS-c (mouse) is a mitochondrial-derived polypeptide that can be used to regulates pancreatic cell function. MOTS-c (mouse) reduces insulin secretion and expression in INS-1E cells, and enhances glucagon secretion and expression in αTC-1 cells. MOTS-c (mouse) decreases the apoptosis in INS-1E and αTC-1. MOTS-c (mouse) counteracts diet-induced obesity and insulin resistance through AMPK activation [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-103642A
CAS No.: 141611-10-1
Purity:  99.8%
Synonyms: Inositol 1,4,5-trisphosphate trisodium; INS(1,4,5)-P3 trisodium
Target:  

Calcium Channel

Research Areas:  

Metabolic Disease

D-myo-Inositol-1,4,5-triphosphate sodium salt is the trisodium salt of D-myo-Inositol 1,4,5-trisphosphate (1,4,5-IP3), which is a second messenger that stimulates the discharge of calcium from the endoplasmic reticulum.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-115403
CAS No.: 1071001-09-6
Purity:  ≥99.0%
Target:  

Phospholipase Apoptosis

Research Areas:  

Metabolic Disease

FKGK18 is a selective group VIA calcium-independent phospholipase A2 (GVIA iPLA2) inhibitor. FKGK18 is a fluoroketone (FK)-based compound with IC50s of 50 nM and 3 μM for iPLA2β and iPLA2γ. FKGK18 can be used for the research of beta-cell apoptosis and diabetes [1] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N0726
CAS No.: 125536-25-6
Synonyms: Dracohodin perochlorate
Dracorhodin perchlorate (Dracohodin perochlorate) is a natural product that can be obtained from the natural active molecule Dragon's blood. Dracorhodin perchlorate inhibits PI3K/Akt and NF-κB activation, upregulates p53 expression, activates caspase, produces ROS, and promotes Apoptosis. Dracorhodin perchlorate regulates the TLR4. Dracorhodin perchlorate promotes wound healing, improves diabetes. Dracorhodin perchlorate has anti-tumor activity against prostate cancer, breast cancer, cervical cancer and other cancers [1] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13529
CAS No.: 1234703-40-2
Purity:  ≥98.0%
Synonyms: LY2608204; SY-004
Target:  

Glucokinase

Research Areas:  

Metabolic Disease

Globalagliatin (LY2608204) is an orally active glucokinase (GK) activator with an EC50 of 42 nM. Globalagliatin also stimulates glucose metabolism in rat insulinoma INS1-E cells with an EC50 of 579 nM. Globalagliatin targets both pancreatic β-cells and hepatocytes. Globalagliatin is promising for research of type 2 diabetes [1] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-103642
CAS No.: 103476-24-0
Synonyms: Inositol 1,4,5-trisphosphate hexapotassium salt; INS(1,4,5)-P3 hexapotassium salt
Target:  

Calcium Channel

Research Areas:  

Metabolic Disease

D-myo-Inositol 1,4,5-trisphosphate hexapotassium salt is the hexapotassium salt of D-myo-Inositol 1,4,5-trisphosphate (1,4,5-IP3), which is a second messenger that stimulates the discharge of calcium from the endoplasmic reticulum.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-137640C
CAS No.: 925456-59-3
Target:  

PKA

Research Areas:  

Inflammation/Immunology Cancer

Rp-8-Br-cAMPS sodium is an analog of cAMP and an inhibitor of PKA. Rp-8-Br-cAMPS sodium occupies cAMP binding sites on PKA type I regulatory subunits, thereby preventing PKA dissociation and activation. Rp-8-Br-cAMPS sodium can be used in the study of tumors and retrovirus-induced immune deficiency. Rp-8-Br-cAMPS sodium also inhibits insulin secretion [1] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P71805
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: INS1; INS-1; INSulin-1
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-150135B
CAS No.: 141611-11-2
Purity:  98.00%
Synonyms: Inositol 1,4,5-trisphosphate tripotassium; INS(1,4,5)-P3 tripotassium
Target:  

Calcium Channel

Research Areas:  

Neurological Disease

D-myo-Inositol 1,4,5-trisphosphate tripotassium, a second messenger, elicits Ca 2+ mobilization. D-myo-Inositol 1,4,5-trisphosphate tripotassium inhibits the binding of phosphoinositide-specific phospholipase C-delta 1 (PLC-delta 1) to bilayer membranes composed of phosphatidylcholine (PC) and phosphatidylinositol 4,5-bisphosphate (PIP2) [1].
loading...
    loading...
Cat. No.: HY-W087027
CAS No.: 1295584-83-6
Maleimide-NOTA is a chelate. Maleimide-NOTA can be site-specifically coupled to the hPD-L1 nanobody bearing the Cys-tag. Maleimide-NOTA can specifically conjugate to A20FMDV2 (HY-P1654). The [ 68Ga]Ac-CG6 formed by the conjugation of 68Ga radiolabeled Maleimide-NOTA with A20FMDV2 can be used for PET imaging of αvβ6 integrin-positive pancreatic ductal adenocarcinoma [1] .
loading...
    loading...
Cat. No.: HY-15671
CAS No.: 851884-87-2
Purity:  99.57%
Target:  

Glucokinase

Research Areas:  

Metabolic Disease

GKA50 is a potent glucokinase activator (EC50=33 nM at 5 mM glucose). GKA50 stimulates insulin release from mouse islets of Langerhans. GKA50 is a glucose-like activator of beta-cell metabolism in rodent and human islets and a Ca 2+-dependent modulator of insulin secretion. GKA50 shows significant glucose lowering in high fat fed female rats [1] .
loading...
    loading...
Cat. No.: HY-N0688
CAS No.: 13476-25-0
Linderane is an orally active natural sesquiterpene lactone with blood-brain barrier permeability. Linderane indirectly activates PDE3 by activating ERK/STAT3, thereby inhibiting the cAMP/PKA/CREB signaling pathway and hepatic gluconeogenesis. Linderane protects pancreatic β cells against oxidative damage by inhibiting the activation of the p38 MAPK pathway and activating the Nrf2 pathway. Linderane inhibits cell apoptosis and ameliorates intestinal mucosal inflammation by suppressing the IL-6/JAK/STAT3 signaling pathway. Linderane reduces pain sensitivity and alleviates anxiety-like behaviors by activating cannabinoid receptor 2 (CB2R). Linderane can be used in studies related to type 2 diabetes, ulcerative colitis, and chronic inflammatory pain with anxiety [1] .
loading...
    loading...
Cat. No.: HY-151257
CAS No.: 2414484-25-4
Purity:  99.05%
Target:  

Hippo (MST)

Research Areas:  

Metabolic Disease

IHMT-MST1-58 is a potent, selective mammalian and orally active STE20-like protein 1 kinase (MST1) inhibitor with IC50 value of 23 nM. IHMT-MST1-58 can be used for the research of Type 1/2 diabetes [1].
loading...
    loading...
Cat. No.: HY-N6005
CAS No.: 3843-74-1
Methyl caffeate is a phenylpropanoid, antibacterial agent, and Apoptosis-inducing agent. Methyl caffeate can be isolated from the flowers of peach Prunus persica (L.). Methyl caffeate upregulates the expression of pro-apoptotic proteins Bid, Bax and p53, and downregulates the expression of anti-apoptotic protein BCL-2. Methyl caffeate downregulates SASP factors. Methyl caffeate enhances glucose-stimulated insulin secretion. Methyl caffeate inhibits the growth of Gram-positive bacteria, Gram-negative bacteria, fungi, and Mycobacterium tuberculosis strains. Methyl caffeate can be used in studies related to breast cancer, type 2 diabetes, and tuberculosis [1] .
loading...
    loading...
Cat. No.: HY-10851
CAS No.: 1128096-64-9
Research Areas:  

Neurological Disease

JNK-9L (Compound 9l) is a BBB-penetrable and ATP-competitive JNK inhibitor with IC50s of 0.099 and 0.148  μM for JNK1 and JNK3, respectively. JNK-9L significantly inhibits c-jun phosphorylation and Streptozotocin (HY-13753)-induced ROS generation with an IC50 of 0.8  nM. JNK-9L can be used for neurodegenerative disorders like Parkinson’s disease research [1].
loading...
    loading...
Cat. No.: HY-143312
CAS No.: 878453-71-5
Purity:  99.86%
Target:  

GLP Receptor

V-0219 is an orally active glucagon-like peptide-1 receptor (GLP-1R) positive allosteric modulator. V-0219 potentiates GLP-1R stimulation, and enhances GLP-1-induced cAMP production and insulin secretion. V-0219 potentiates glucose-dependent insulin secretion. V-0219 improves glucose handling in normal and diabetic rodents. V-0219 can be used for the research of obesity-associated diabetes [1].
loading...
    loading...